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Abstract
Introduction: Based on international experiences and altering demography the reference intervals (RI) for haemoglobin (Hb) concentrations in 
blood were changed in Denmark in 2013 from 113 - 161 g/L to 117 - 153 g/L for women and from 129 - 177 g/L to 134 - 170 g/L for men. The aim 
of this study was to determine the derived change in prevalence of anaemia and the change in yearly health care costs of diagnostic investigations 
associated with the expected, as we hypothesized, increased prevalence and health care costs.
Materials and methods: Data from 96,314 non-hospitalised patients (55,341 females and 40,973 males, aged 18 - 105 years) from general prac-
titioners and community specialists of Funen, Denmark, were extracted from the laboratory information system. The prevalence of anaemia accor-
ding to the new and the old RI were investigated, and additional costs were calculated based on estimated additional blood analyses and nationally 
recommended endoscopic procedures.
Results: Changing the Hb RI increased the number of anaemic patients by 52% (3450 patients) over a two-year period. With new RI the proportion 
of anaemic elderly above 80 years was 20.5% for females and 43.9% for males. Annual costs of derived additional assessments due to the altered RI 
were estimated to be 5.7 million €, which equals the cost of 1214 knee replacement surgeries in Denmark.
Conclusions: Changing the Hb RI has been expensive, despite the fact that no outcome studies have justified the alteration. The methodological 
approach for establishing new RI, here particularly for Hb, should be thoroughly considered. In general, physicians should use RI with caution.
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Introduction
Anaemia is important in clinical medicine. Al-
though a number of different cut-off values for 
haemoglobin have been suggested, general prac-
titioners often consider a patient anaemic if the 
concentration of haemoglobin (Hb) in the blood is 
below the established reference intervals (1). Anae-
mia can be physiological due to pregnancy, it can 
be due to deficiency of e.g. iron, cobalamin or 
folate, or it can be caused by bleeding, malignancy 
or chronic illnesses (2). Anaemia is associated with 
poorer outcome of a variety of diseases and previ-
ous studies have shown that anaemia increases 
the risk of hospitalization and mortality in the el-
derly, mortality in patients with acute ischaemic 
stroke, and risk of complications due to chronic ill-
ness such as kidney failure (3-5).
The definition of anaemia and thereby the optimal 
Hb reference intervals has been widely discussed 
during the last decade, because it is evident that 
reference intervals must reflect the population for 
whom they are used. As a result, reference inter-
vals for Hb and how they are established differ be-
tween countries. Also, the use of cut-off values has 
been introduced: a World Health Organisation 
(WHO) expert committee presented in 1968 a re-
port defining the criteria for diagnosis of anaemia, 
a report that has been revised in 1989, with cut-
offs defining mild, moderate and severe anaemia, 
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and recently addressed in the WHO Vitamin and 
Mineral Nutrition Information System, where an 
updated report presents adjustments due to 
smoking status, residence above sea level, preg-
nancy and others (1,6,7). Nevertheless, general 
practitioners generally support their decision-
making on the reference intervals given by the 
laboratory and are not always aware of the differ-
ent cut-offs or the abovementioned sub-specified 
classifications. Therefore, the WHO Hb reference 
intervals have been questioned in multiple cases, 
initiated by Beutler and Waalen, who in 2006 
showed that normal Hb concentrations among 
healthy adult men and healthy adult non-preg-
nant women did not fit the reference intervals 
suggested by the WHO (6,8). Before the change, 
these reference intervals had been used for nearly 
40 years, and Beutler and Waalen demonstrated 
that the WHO reference intervals were based on a 
study with very few data using an inadequate 
analysis method (8). 
In 2004, Nordin et al. conducted a reference inter-
val study in the Nordic countries: most of the 1826 
observations in this study were from Finland and 
Sweden, while only approximately 13% were from 
Denmark; the participants were healthy non-preg-
nant females and healthy males between 18 and 
90 years with a mean age of 46 and 48 years, re-
spectively (9). The Hb 2.5 - 97.5 percentiles were 
117 - 153 g/L for females and 134 - 170 g/L for 
males. As a consequence Danish Hb reference in-
tervals were changed in 2013 from 113 - 161 g/L to 
117 - 153 g/L and 129 - 177 g/L to 134 - 170 g/L for 
women and men ≥ 18 years, respectively. It is 
worth mentioning that a similar change has been 
conducted in many other countries, e.g. the United 
States of America and Germany.
We are not aware of studies that have estimated 
the impact of altered Hb reference intervals in the 
general population in terms of increased number 
of anaemic persons and estimations of the derived 
health care costs. Furthermore, no outcome stud-
ies have been conducted to justify the alteration. 
The aim of this study was therefore to elucidate 
the consequences of changing the Danish Hb ref-
erence intervals in terms of anaemia diagnoses 
and estimated altered economic expenses. Also, 
we wanted to determine the most likely causes for 
previously undiagnosed anaemia in order to cal-
culate the fraction of iron deficiency anaemia (IDA) 
in our population and the hereof derived costs of 
endoscopic procedures, and to determine if the 
fraction of IDA was the same before and after the 
changes of the Hb reference intervals. As the refer-
ence intervals were narrowed, we hypothesised an 
increase in the prevalence of anaemia and an in-
crease in the economic expenses due to more pa-
tients in need of additional investigations.
Materials and methods
In Denmark, general practitioners and community 
specialists submit their blood samples for analysis 
at hospital-based laboratories. The Department of 
Clinical Biochemistry and Pharmacology at Odense 
University Hospital analyses blood samples for the 
majority of general practitioners and community 
specialists on the island of Funen. Funen compris-
es approximately 381,096 inhabitants ≥ 18 years, 
corresponding to 8% of the Danish population 
above 18 years (10).
Subjects
Data from the observed two-year period were ex-
tracted from the laboratory information system at 
Odense University Hospital, containing 214,210 Hb 
requests either by a general practitioner or a com-
munity specialist. All samples were identified by 
the unique and permanent ID number that all 
Danes carry. For anonymization these ID numbers 
were given a temporary unique ID number allow-
ing identification of repeated measurements for 
the same person. No data were referable to spe-
cific individuals and therefore, permissions from 
Danish authorities were not required.
All Hb measurements were performed on a Sysmex 
XN9000 (Sysmex Nordic, Copenhagen, Denmark) in 
whole blood stabilised with tripotassium ethylene-
diaminetetraacetic acid (EDTA-K3). Only the first 
blood sample with Hb concentration was included, 
which left 102,137 Hb observations in the data set. 
Furthermore, 518 observations were missing due to 
failed analyses and were excluded, and 5305 Hb val-
ues for persons under 18 years were also excluded. 
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The final number of Hb observations entering the 
analysis was 96,314, hereof 55,341 females and 
40,972 males aged 18 - 105 years.
For each patient the following analyses results 
were also retrieved, if they were present within 
seven days of the included Hb sample: plasma (P)-
ferritin, mean erythrocyte corpuscular volume 
(MCV), P-cobalamin, P-folate, P-creatinine and P-C-
reactive protein (P-CRP). Among the included Hb 
measures, a total of 15,764 P-ferritin, 14,089 MCV, 
20,558 P-cobalamin, 9444 P-folate, 86,610 P-creati-
nine, and 35,029 P-CRP were available.
Observations were categorized by sex and divided 
into nine age groups. Patients were also divided 
into groups of “anaemia by old reference intervals” 
and “anaemia by new reference intervals”. “Anae-
mia by old reference intervals” was defined as 
those with anaemia by the old reference interval. 
“Anaemia by new reference intervals” was defined 
as those with anaemia by the old reference inter-
vals and the additional number of patients with 
anaemia by the new reference intervals.
Anaemia and cost of additional investigations
In order to estimate the additional costs that new 
reference intervals may generate, we defined a 
“blood analysis package” for all with anaemia and 
endoscopic procedures for a selection of patients 
with iron-deficiency anaemia. The blood analysis 
package contained measurement of Hb, MCV, 
mean erythrocyte corpuscular haemoglobin con-
centration (MCHC), reticulocytes, leukocytes includ-
ing a differential count, thrombocytes, P-ferritin, P-
iron, P-transferrin, P-folate, P-cobalamin, P-lactate 
dehydrogenase, P-bilirubin, P-haptoglobin, P-cre-
atinine and P-CRP. Costs of these additional analy-
ses alone (9.79 €) as well as the costs of blood sam-
pling (1/30 of a full working day for a laboratory 
technician, i.e. 265.95 €) were estimated to be 18.63 
€ for the blood analysis package.
Prices for endoscopic procedures were estimated to 
be 406 € for gastroscopy and 618 € for bidirectional 
(both gastroscopy and colonoscopy) endoscopy 
based on Danish national diagnosis-related group 
procedure hospital rates (11). The number of pa-
tients in need of bidirectional endoscopy was de-
termined by national guidelines from the Danish 
Medical Society of Gastroenterology and Hepatolo-
gy (DSGH): the DSGH guidelines for endoscopic 
procedures only apply to those with IDA, which in-
volves approximately 50% of all with anaemia in the 
Danish population (12). DSGH guidelines suggest 
that all patients older than 40 years with IDA should 
be referred to bidirectional endoscopy due to can-
cer suspicion. Patients younger than 40 years with 
IDA should be biochemically screened for celiac dis-
ease with measurements of transglutaminase anti-
bodies and IgA. In this age group it was assumed 
that approximately 4% would turn out positive 
based on the prevalence of celiac disease in pa-
tients with IDA (13). Patients younger than 40 years 
who were biochemically positive for celiac disease 
were estimated to be referred to gastroscopy alone; 
however, if biochemically negative they were re-
ferred to bidirectional endoscopy under suspicion 
of cancer, unless they were female and premeno-
pausal which applies to 99% of females younger 
than 40 years (14). Among these patients, IDA was 
considered physiological without further need of 
investigation.
To ensure that our data matched the assumption 
that approximately 50% of all with anaemia in 
Denmark had IDA, we investigated the frequency 
of anaemia due to IDA, anaemia of other known 
causes (AOKC) (categorized as deficiency of cobal-
amin, folate, or anaemia due to kidney failure), 
anaemia by chronic disease (ACD) or unclassified 
anaemia. IDA was defined as follows: patients with 
anaemia and P-ferritin < 30 μg/L, or patients with 
anaemia and P-ferritin 30 - 60 μg/L and P-CRP < 10 
mg/L, or patients with anaemia and P-ferritin < 
100 μg/L and P-CRP > 10 mg/L (12). AOKC were de-
fined as patients with anaemia and P-cobalamin < 
120 pmol/L and MCV > 103 fL, or anaemia and P-
folate < 6 nmol/L, P-cobalamin > 120 pmol/L and 
MCV > 103 fL, or anaemia and P-creatinine > 150 
μmol/L. ACD was defined as P-CRP > 10 mg/L and 
P-ferritin > 100 μg/L (12).
In order to adjust for differences in price levels 
across countries, additional costs were compared 
to Danish costs of knee alloplastic surgery: in Den-
mark, the diagnosis-related group price of one ad-
vanced knee reconstruction is 4734 € (9).
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Statistical analyses
Normal distribution of Hb values was assessed 
from histograms for each age group. The 2.5 and 
97.5 percentiles were found with 95% confidence 
intervals (CI) for all patients, patients between 18 
and 89 years, patients between 18 and 69 years 
and for all patients divided into age groups by 
decade; all subdivided by sex. The proportions of 
anaemia by the old and new reference intervals re-
spectively were derived for each sex and age 
group. All data processing was conducted using 
Stata IC 13 (StataCorp LLC, Texas, USA).
Results
Table 1 illustrates the distribution of Hb by sex, 
age, and the 2.5 and 97.5 percentiles for Hb con-
centrations in these groups. In both sexes the 2.5 
percentile was lower for all groups compared to 
the lower limits for the old as well as the new refer-
ence intervals.
Table 2 shows the proportions of patients with 
anaemia by the old and the new reference inter-
vals, respectively, categorized by age. Using the 
old reference intervals 6578 (6.8%) patients were 
anaemic compared to 10,028 (10.4%) using the 
new reference interval, i.e. an additional 3450 pa-
tients with anaemia corresponding to a 52% in-
crease in prevalence of the diagnosis of anaemia. 
The additional proportion with anaemia ranged 
between 3 - 9% of all observations in women and 
0.5 - 13% of all observations in men across the dif-
ferent age groups. With the new reference inter-
vals an additional 1731 (3.1%) women and an addi-
tional 1719 (4.2%) men were defined as anaemic.
Table 3 illustrates that there were 1475 patients 
with IDA out of 2583 with anaemia and ferritin val-
ue for both sexes (57.1% (95%CI 55.2 - 59.0)) with 
the old reference interval, compared to 1979 pa-
tients with IDA out of 3431 with anaemia and ferri-
tin value for both sexes (57.7% (95%CI 56.0 - 59.3)) 
with the new reference interval. With the new ref-
erence intervals 5222 of 10,028 patients with anae-
mia (52.1% (95%CI 51.1 - 53.1)) were categorized as 
”unclassified anaemia”, while only 2983 of 6578 pa-
tients with anaemia (45.3% (95%CI 44.1 - 46.6)) 
were categorized as ”unclassified anaemia” using 
the old reference interval.
As shown in Figure 1, the proportion of individuals 
with anaemia increased considerably with age for 
both sexes and with both Hb reference intervals, 
Age (years) Hb, females (g/L) Hb, males (g/L)
N 2.5 percentile (95% CI)
97.5 percentile
(95% CI) N
2.5 percentile
(95% CI)
97.5 percentile
(95% CI)
18-105 55,341 103 (103-105) 156 (156-156) 40,973 109 (109-111) 171 (171-172)
18-89 54,124 105 (105-105) 156 (156-156) 40,540 111 (109-111) 172 (171-172)
18-69 41,879 108 (106-108) 156 (156-156) 30,808 122 (121-122) 172 (172-172)
18-19 1137 109 (106-113) 153 (151-155) 580 135 (134-137) 171 (169-172)
20-29 6990 106 (106-108) 153 (153-155) 3514 132 (130-134) 174 (174-175)
30-39 6264 106 (105-108) 153 (153-153) 3684 132 (130-134) 172 (172-174)
40-49 8813 103 (101-105) 156 (155-156) 6128 129 (127-130) 172 (172-174)
50-59 9134 111 (109-113) 156 (156-158) 7850 122 (121-124) 172 (172-172)
60-69 9541 111 (109-113) 158 (158-159) 9052 113 (109-114) 171 (171-171)
70-79 7572 101 (100-104) 158 (156-158) 6782 103 (100-103) 169 (167-169)
80-89 4673 93 (92-95) 156 (155-158) 2950 95 (92-97) 164 (164-166)
≥ 90 1217 89 (87-93) 150 (148-152) 433 85 (74-89) 161 (156-163)
Hb - haemoglobin concentrations. 95% CI - 95% confidence intervals.
Table 1. Haemoglobin concentration by age and sex among 96,314 Danish patients from general practitioners
https://doi.org/10.11613/BM.2017.030702 Biochem Med (Zagreb) 2017;27(3):030702 
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Women
Age (years) 18-19 20-29 30-39 40-49 50-59 60-69 70-79 80-89 ≥90 Total
Anaemia by old reference intervals
Anaemia (N) 38 273 285 458 242 258 461 638 283 2936
Proportion within 
age group (%)
3.3%
(2.4-4.6)
3.9%
(3.5-4.4)
4.6%
(4.1-5.1)
5.2%
(4.8-5.7)
2.7%
(2.4-3.0)
2.7%
(2.4-3.0)
6.1%
(5.6-6.6)
13.7%
(12.7-14.7)
23.3%
(21.0-25.7)
5.3%
(5.1-5.5)
Anaemia by new reference intervals
Anaemia (N) 68 469 494 717 397 434 742 959 387 4667
Proportion within 
age group (%)
6.0%
(4.7-7.5)
6.7%
(6.1-7.3)
7.9%
(7.2-8.5)
8.1%
(7.5-8.7)
4.4%
(3.9-4.8)
4.5%
(4.1-4.9)
9.8%
(9.1-10.5)
20.5%
(19.4-21.7)
31.8%
(29.2-34.5)
8.4%
(8.2-8.7)
Men
Anaemia by old reference intervals
Anaemia (N) 3 41 58 133 309 734 1145 1003 216 3642
Proportion within 
age group (%)
0.5%
(0.2-1.6)
1.2%
(0.8-1.5)
1.6%
(1.2-2.0)
2.2%
(1.8-2.6)
3.9%
(3.5-4.4)
8.1%
(7.6-8.7)
16.9%
(16.0-17.8)
34.0%
(32.3-35.7)
49.9%
(45.2-54.6)
8.9%
(8.6-9.2)
Anaemia by new reference intervals
Anaemia (N) 6 101 107 236 535 1166 1643 1296 271 5361
Proportion within 
age group (%)
1.0%
(0.5-2.2)
2.9%
(2.4-3.5)
2.9%
(2.4-3.5)
3.9%
(3.4-4.4)
6.8%
(6.3-7.4)
12.9%
(12.2-13.6)
24.2%
(23.2-25.3)
43.9%
(42.1-45.7)
62.6%
(58.0-67.0)
13.1%
(12.8-13.4)
Proportions are presented with corresponding 95% confidence intervals.
Table 2. Numbers and proportions of patients with anaemia among Danish patients from general practitioners
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Figure 1. Fraction of anaemic individuals by age for the old and 
the new reference intervals
however with higher prevalence for both sexes us-
ing the new reference intervals.
When extrapolated to the entire Danish popula-
tion, 37,771 patients would be diagnosed with 
anaemia every year using the old reference inter-
vals, while 57,581 would be anaemic using the new 
reference intervals. As a result, an estimated addi-
tional 19,810 blood analysis packages, 8647 bidi-
rectional endoscopies and 62 gastroscopies would 
be performed yearly with additional yearly costs 
of 370,000 €, 5.34 million € and 25,000 €, respec-
tively. Altogether, the additional yearly costs in 
Denmark due to the change in Hb reference inter-
vals would be an estimated 5.7 million €, equalling 
the costs of 1214 knee replacement surgeries.
Discussion
Our study shows that the changed lower reference 
intervals for Hb possibly increases the prevalence of 
anaemia by 52%. To our knowledge, this is the first 
population-based study that reports on this and on 
the estimated economic consequences of changing 
Hb reference intervals. As shown, this theoretical in-
crease has the potential to massively increase the 
costs for anaemia assessment in Denmark with the 
most pronounced increase in prevalence of the di-
agnosis of anaemia in the elder age groups. Of note, 
no public health advantages or disadvantages have 
been shown to justify the changes or the derived 
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Type of anaemia for patients with anaemia by old reference intervals
Anaemia (N) 1032 444 288 1172 2936 1426 443 849 539 1811 3642 1157
Anaemia by 
respective 
type (%)
35.1
(32.2-35.4)
15.1 
(13.6-16.0)
9.8 
(8.6-10.6)
39.9 
(40.2-43.6) 100 -
12.2 
(11.1-13.3)
23.3
(22.0-24.7)
14.8
(13.7-16.0)
49.7
(48.1-51.3) - -
Anaemia by 
respective 
type and 
ferritin 
value (%)
72.4 
(70.0-74.6) -
20.2
(18.5-22.5) - - 100
38.3 
(35.5-41.1)
46,6 
(43.7-49.5) - - -
Type of anaemia for patients with anaemia by new reference intervals
Anaemia (N) 1430 678 393 2166 4667 1970 549 1082 674 3056 5361 1461
Anaemia by 
respective 
type (%)
30.6 
(29.3-32.0)
14.5 
(13.5-15.6)
8.4
(7.7-9.3)
46.4 
(45.0-47.8) 100 -
10.2 
(9.5-11.1)
20.2 
(19.1-21.3)
12.6 
(11.7-13.5)
57.0 
(55.7-58.3) - -
Anaemia by 
respective 
type and 
ferritin 
value (%) 
72.6 
(70.6-74.5)
19.9
(18.2-21.8) - - 100
37.6 
(35.1-40.1)
46.1 
(43.6-48.7) - - -
The sub-group comprised 96,314 Danish patients, who had additional blood investigations from general practitioners within seven 
days of the included Hb sample. Proportions are presented with corresponding 95% confidence interval (CI). IDA - iron-deficiency 
anaemia. AOKC - anaemia by other known causes (deficiency of cobalamin, folate, etc.). ACD - anaemia of chronic disease. 
Table 3. Anaemia types among the Danish patients sub-group  
costs, and to our knowledge, no studies have inves-
tigated whether changing the Hb reference inter-
vals actually altered long-term morbidity and mor-
tality in this population.
In general, alterations of reference intervals must 
be scientifically based, in terms of not only under-
lying demographic data, but also the considera-
tions of what the alterations will lead to in terms of 
increased/decreased diagnoses, altered treat-
ments etc. If the alterations are not evidence-
based, they can be expensive and lead to unnec-
essary and potentially harmful assessments. Stud-
ies have shown that the Hb level is affected both 
by ethnicity and age, and reference intervals 
should therefore in general not be adopted from 
other countries or districts without a local valida-
tion (8,15-17). The Danish population has a grow-
ing immigrant population. In 2014, approximately 
11.1% of the adult Danish population were consid-
ered immigrants or descendants, and this could af-
fect the prevalence of anaemia due to ethnicity 
(10). As the study by Nordin et al. was conducted in 
2004 in a Swedish and Finnish population it is like-
ly that the population does not match the Danish 
population in 2013-2015 (9). Furthermore, the 
study by Nordin et al. had a mean age approxi-
mately 10 years younger for males and 6 years 
younger for females compared to our study popu-
lation. They did not divide individuals into age 
groups and reported that few cases were older 
than 75 years. As demonstrated in Table 1 elderly 
(≥ 70) age groups have a significantly lower Hb 2.5 
percentile concentration and thereby a larger pro-
portion of anaemia following this definition. This is 
https://doi.org/10.11613/BM.2017.030702 Biochem Med (Zagreb) 2017;27(3):030702 
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also evident from Figure 1 that shows a considera-
ble increase in the prevalence of anaemia already 
above 50 years of age. However, if a condition is 
present in almost 50% of the population (for men 
above 80 years), it could indicate that the defini-
tion does not fit the entire population, but rather 
is defined from studies conducted in a younger 
population.
Tettamanti et al. also described increased anaemia 
prevalence for elderly over 65 years, where 26.4% 
of patients with mild anaemia were unexplained 
while up to one third of the elderly with mild anae-
mia might be accounted for by myelodysplastic 
syndrome (17). Willems et al. found that approxi-
mately 30% of elderly with anaemia remained un-
explained and found a tendency of lower Hb in el-
derly with an underlying pathology compared to 
the anaemic elderly with unexplained anaemia 
(18). As suggested by Merchant and Roy, haema-
tologists needs to address better guidelines for Hb 
targets for the elderly and must investigate the 
molecular pathogenesis of anaemia in the elderly 
more thoroughly (19).
The strength of our study is the wide selection of 
the population over a two-year period. In addition, 
the use of laboratory data allows the study to be 
repeated with renewed data. Therefore, it can be 
used for Hb monitoring in a population at a very 
low cost. Our study also has limitations. First, the 
data does not include finger prick Hb measure-
ments from the general practitioners of Funen. Sec-
ond, the study does not provide any information on 
causation such as illness, on-going treatment and 
pregnancies, which could imply selection bias and 
cause an overestimation of the fraction of patients 
with anaemia. In order to minimize the number of 
patients already receiving treatment for anaemia 
we included only the first Hb measurement. Fur-
thermore, the number of pregnant women with 
anaemia due to haemodilution could be reduced as 
pregnant women in Denmark are followed regular-
ly, with the first consult in the middle of the first tri-
mester. At this appointment physicians are en-
couraged to screen for anaemia (20,21). 
The real expenses in Denmark probably differs 
from our results as the DSGH guidelines that were 
revised in 2014 using Hb reference intervals sug-
gested by the WHO (Hb < 120 g/L for females and 
< 130 g/L for males) (12). We did not include diag-
nostic procedures such as bone marrow biopsies, 
haemoglobin analyses of stool samples, or fees for 
extra doctor appointments and special blood 
samples indicating that our estimated yearly addi-
tional costs are likely to be conservative. Finally, 
we only investigated the consequences of chang-
ing the lower limit of the reference intervals. The 
upper limit was lowered in the current Hb refer-
ence intervals; this could increase the number of 
patients being assessed for polycythaemia. Fur-
thermore, our retrospective data do not take into 
account that blood sampling has shown a steady 
increase during the past decades that could in-
crease the costs even more.
Health care budgets are limited and the derived 
consequences of changing reference intervals 
must be a part of the decision process in general. 
To our knowledge, no studies have shown any 
population benefits of the new, narrower Hb refer-
ence intervals. As the prevalence of anaemia is de-
pendent on the prevalence of several diseases it 
should be considered whether the 2.5 and 97.5 
percentile is the best way to determine reference 
intervals for Hb. Reference intervals based on Hb 
value limits, where the risk of underlying patholo-
gy is significant, might be more cost-effective.
With a generally increasing tendency towards de-
fensive medicine, reference intervals are extreme-
ly important parameters when deciding whom to 
investigate further. It is therefore an important re-
sponsibility the decision makers, here the labora-
tory society, has to carry, namely to assure that al-
terations such as this are evidence-based and well 
founded – and to inform the treating physicians if 
over-diagnosing seems to take place. However, it 
is necessary for physicians to keep in mind that 
there can be considerable sex-, age- and ethnicity-
related differences in Hb concentrations, and as 
emphasized in the WHO guideline, to consider 
other contributory factors, e.g. smoking and sea 
level (7). Therefore, the diagnosis of anaemia 
should always be decided in context with other 
blood analyses and clinical symptoms. Of impor-
tance, extensive diagnostic programs should nev-
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er be based on a single finding of mild anaemia 
without symptoms. 
In conclusion, changing the Hb reference intervals 
increased the prevalence of the diagnosis of anae-
mia by 52%, which may increase heath care ex-
penditures considerably due to additional investi-
gations. Whether this actually happens, and what 
impact it will have on morbidity and mortality 
warrants further investigations.
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